These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
256 related items for PubMed ID: 7961025
1. Combined cytokinesis-block micronucleus and chromosomal aberration assay for the evaluation of radiosensitizers at low radiation doses. Oya N, Shibamoto Y, Shibata T, Sasai K, Sugiyama T, Abe M. Int J Radiat Oncol Biol Phys; 1994 Dec 01; 30(5):1153-9. PubMed ID: 7961025 [Abstract] [Full Text] [Related]
2. In vivo radiosensitization efficacy of KU-2285 and etanidazole at clinically relevant low radiation doses. Oya N, Shibamoto Y, Sasai K, Sugiyama T, Abe M. Int J Radiat Oncol Biol Phys; 1993 Dec 01; 27(5):1113-9. PubMed ID: 8262836 [Abstract] [Full Text] [Related]
3. Radiosensitization efficacy of KU-2285, RP-170 and etanidazole at low radiation doses: assessment by in vitro cytokinesis-block micronucleus assay. Shibamoto Y, Streffer C, Sasai K, Oya N, Abe M. Int J Radiat Biol; 1992 Apr 01; 61(4):473-8. PubMed ID: 1349329 [Abstract] [Full Text] [Related]
4. Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity. Oya N, Shibamoto Y, Sasai K, Shibata T, Murata R, Takagi T, Iwai H, Suzuki T, Abe M. Int J Radiat Oncol Biol Phys; 1995 Aug 30; 33(1):119-27. PubMed ID: 7642409 [Abstract] [Full Text] [Related]
5. KIN-804 vs. KU-2285 as a radiosensitizer for clinical use. Oya N, Shibamoto Y, Shibata T, Murata R, Iwai H, Sugiyama T, Abe M. Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):595-600. PubMed ID: 8005822 [Abstract] [Full Text] [Related]
6. A fluorinated 2-nitroimidazole, KU-2285, as a new hypoxic cell radiosensitizer. Sasai K, Nishimoto S, Shimokawa K, Hisanaga Y, Kitakabu Y, Shibamoto Y, Zhou L, Wang J, Takahashi M, Kagiya T. Int J Radiat Oncol Biol Phys; 1991 Jun 15; 20(6):1249-54. PubMed ID: 1828462 [Abstract] [Full Text] [Related]
7. Comparison of radiosensitizing effect of KU-2285 and SR-2508 at low drug concentrations and doses. Shibata T, Shibamoto Y, Oya N, Sasai K, Murata R, Ishigaki T, Abe M. Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):587-90. PubMed ID: 8005820 [Abstract] [Full Text] [Related]
8. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343). Murayama C, Suzuki A, Sato C, Tanabe Y, Shoji T, Miyata Y, Nishio A, Suzuki T, Sakaguchi M, Mori T. Int J Radiat Oncol Biol Phys; 1993 Jun 15; 26(3):433-43. PubMed ID: 8514541 [Abstract] [Full Text] [Related]
9. Clinical trials of radiosensitizers: what should we expect? Brown JM. Int J Radiat Oncol Biol Phys; 1984 Mar 15; 10(3):425-9. PubMed ID: 6231272 [Abstract] [Full Text] [Related]
10. Radiosensitization by 2-nitroimidazole nucleoside analog RP-170: radiosensitizing effects under both intravenous and oral administration. Murayama C, Suzuki A, Sato C, Tanabe Y, Miyata Y, Shoji T, Suzuki T, Sakaguchi M, Mori T. Int J Radiat Oncol Biol Phys; 1992 Mar 15; 22(3):557-60. PubMed ID: 1531214 [Abstract] [Full Text] [Related]
11. Tirapazamine: hypoxic cytotoxicity and interaction with radiation as assessed by the micronucleus assay. Shibata T, Shibamoto Y, Sasai K, Oya N, Murata R, Takagi T, Hiraoka M, Takahashi M, Abe M. Br J Cancer Suppl; 1996 Jul 15; 27():S61-4. PubMed ID: 8763848 [Abstract] [Full Text] [Related]
13. Metabolic studies and neurotoxicity in tumors and brain of mice after hypoxic cell sensitizers. Streffer C, Tamulevicius P. Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):571-5. PubMed ID: 8005816 [Abstract] [Full Text] [Related]
14. Tumor radiosensitivity prediction by the cytokinesis-block micronucleus assay. Shibamoto Y, Streffer C, Fuhrmann C, Budach V. Radiat Res; 1991 Dec 15; 128(3):293-300. PubMed ID: 1961926 [Abstract] [Full Text] [Related]
15. Radiosensitization of hypoxic cells in vivo by SR 2508 at low radiation doses: a preliminary report. Brown JM, Yu NY. Int J Radiat Oncol Biol Phys; 1984 Aug 15; 10(8):1207-12. PubMed ID: 6236184 [Abstract] [Full Text] [Related]
16. A comparison of radiosensitization by etanidazole and pimonidazole in mouse tumors. Stone HB, Hirst VK, Cribbs R, Luu YH, Brown JM. Int J Radiat Oncol Biol Phys; 1991 May 15; 20(5):987-95. PubMed ID: 1827089 [Abstract] [Full Text] [Related]
17. Automation of the in vitro micronucleus and chromosome aberration assay for the assessment of the genotoxicity of the particulate and gas-vapor phase of cigarette smoke. Roemer E, Zenzen V, Conroy LL, Luedemann K, Dempsey R, Schunck C, Sticken ET. Toxicol Mech Methods; 2015 May 15; 25(4):320-33. PubMed ID: 25986082 [Abstract] [Full Text] [Related]
18. Sensitization by SR-2508 plus Ro 03-8799. Stone HB, Luu YH, Lam KN. Int J Radiat Oncol Biol Phys; 1986 Jul 15; 12(7):1097-100. PubMed ID: 2943707 [Abstract] [Full Text] [Related]
19. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170). Murayama C, Suzuki A, Suzuki T, Miyata Y, Sakaguchi M, Tanabe Y, Tanaka N, Mori T. Int J Radiat Oncol Biol Phys; 1989 Sep 15; 17(3):575-81. PubMed ID: 2528527 [Abstract] [Full Text] [Related]
20. Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors. Masunaga S, Ono K, Sakurai Y, Takagaki M, Kobayashi T, Kinashi Y, Suzuki M. Int J Radiat Oncol Biol Phys; 2001 Nov 01; 51(3):828-39. PubMed ID: 11697329 [Abstract] [Full Text] [Related] Page: [Next] [New Search]